Dementia & Alzheimers Disease

Dementia is a general term for when a person has developed difficulties with judgement, reasoning and memory. Dementia can be caused by several types of disease however the most common (60 to 80% of cases) is Alzheimers disease. Read more below on risk factors, symptoms, medical treatments and lifestyle considerations. We’ve also linked the Alzheimers …

Dementia & Alzheimers Disease Read More »

Dementia cases to triple by 2050

The incidence of Dementia is set to triple in the next 30 years owing to population growth and longer life expectancy. The study examined 4 major risk factors: obesity, high blood sugar, smoking and level of education. Read more below.. https://www.imt.ie/clinical/global-dementia-cases-to-triple-by-2050-study-14-01-2022/ We’ve added an education update covering Dementia & Alzheimers from uptodate.com be sure to …

Dementia cases to triple by 2050 Read More »

COPD – CPD overview

Called for CPD? Get the ball rolling with this nice summary article on COPD from the Irish Medical Times & in-depth article from the Irish medicines management programme. Read more below.. https://www.hse.ie/eng/about/who/cspd/ncps/medicines-management/guidance/inhaled-medicines-for-copd.pdf Clinical Update: COPD  

Roactemra supply pressure to continue as EMA approves COVID-19 indication

Ongoing Roactemra supply difficulties are set to continue as the European Medicines Agency approves its use for adults with severe COVID-19  who are in receipt of systemic treatment with corticosteroids and requiring supplemental oxygen or mechanical ventilation. Read more below.. RoActemra (tocilizumab) approved by EMA for use in severe COVID-19    

New Oral Anti-Covid Treatments – get full details here

Oral anti-Covid treatments have been developed and licenced for use – Lagevrio and Paxlovid. Dr JJ Keating and Dr Tim O’Sullivan from the UCC School of Pharmacy explain everything in this article. https://www.rte.ie/brainstorm/2021/1207/1265254-covid-19-antiviral-drugs-pfizer-merck-lagevrio-paxlovid-molnupiravir-ritonavir/ SPC link for Lagevrio: https://www.medicines.org.uk/emc/product/13044/smpc#gref      

Risk of Long-Covid halved with double vaccination -The Lancet

Data published in The Lancet has found that the risk of having COVID symptoms for 28 days or more after post-vaccination infection were approximately halved. Read more below.. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00460-6/fulltext#seccestitle150

Missed World Antibiotic Awareness week (18-24 Nov)? Check out these links!

Did you know that co-amoxiclav should not be used first line in the community other than for animal or human bite, facial cellulitis, post partum endometritis, caesarean wound infections or perineal wound infection? Check out the HSE green/red table link below for antibiotic prescribing in the community. Print and stick it on the wall! Great …

Missed World Antibiotic Awareness week (18-24 Nov)? Check out these links! Read More »